Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.90% | 33.71% | 107.53% | -28.73% | -30.32% |
| Total Receivables | -20.00% | 50.00% | -65.00% | -- | -44.44% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.08% | 2.05% | -7.43% | -63.24% | -54.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.60% | -74.64% | -16.01% | -- | -10.07% |
| Total Current Assets | -3.89% | 17.36% | 86.48% | -32.06% | -33.90% |
|
|
|||||
| Total Current Assets | -3.89% | 17.36% | 86.48% | -32.06% | -33.90% |
| Net Property, Plant & Equipment | -32.62% | -32.57% | -32.76% | -34.38% | -32.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | -2.34% | 11.18% | 30.73% | -13.00% | -15.57% |
|
|
|||||
| Total Accounts Payable | 16.55% | 69.03% | 72.81% | -17.02% | 31.34% |
| Total Accrued Expenses | 18.87% | -20.14% | 0.00% | 17.32% | 45.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.28% | 13.71% | 14.17% | 13.79% | 14.29% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.69% | 15.46% | 27.90% | 1.59% | 37.71% |
|
|
|||||
| Total Current Liabilities | 17.69% | 15.46% | 27.90% | 1.59% | 37.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.66% | -43.25% | -37.99% | -33.85% | -30.48% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.81% | -99.76% | -- | 316.16% | 1,106.16% |
| Total Liabilities | -66.97% | -60.99% | 24.54% | 197.03% | 265.41% |
|
|
|||||
| Common Stock & APIC | 48.54% | 46.41% | 20.31% | 22.47% | 1.08% |
| Retained Earnings | -35.26% | -36.95% | -19.46% | -46.26% | -18.84% |
| Treasury Stock & Other | -68.42% | -36.84% | 124.39% | -1,200.00% | -280.00% |
| Total Common Equity | 261.72% | 36,050.00% | 33.89% | -459.94% | -140.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 261.72% | 36,050.00% | 33.89% | -459.94% | -140.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 261.72% | 36,050.00% | 33.89% | -459.94% | -140.47% |
|
|
|||||